#METABOLOMICS WORKBENCH clambert_20240802_043609 DATATRACK_ID:5074 STUDY_ID:ST003401 ANALYSIS_ID:AN005582 PROJECT_ID:PR002107 VERSION 1 CREATED_ON August 13, 2024, 3:13 pm #PROJECT PR:PROJECT_TITLE The double-edged role of FASII regulator FabT in Streptococcus pyogenes PR:PROJECT_TITLE infection PR:PROJECT_TYPE MS quantitative analysis PR:PROJECT_SUMMARY In Streptococcus pyogenes, the type II fatty acid (FA) synthesis pathway FASII PR:PROJECT_SUMMARY is feedback-controlled by the FabT repressor. A FabT mutation leads to FASII PR:PROJECT_SUMMARY dysregulation, FAs membrane modification and bacterial growth defect in the PR:PROJECT_SUMMARY presence of eukaryotic cells and their supernatant. We try to understand the PR:PROJECT_SUMMARY consequences on bacteria metabolism. PR:INSTITUTE INSERM PR:DEPARTMENT U1016 PR:LABORATORY Institut Cochin - Bacteria and perinatality team PR:LAST_NAME Lambert PR:FIRST_NAME Clara PR:ADDRESS 24 rue Méchain 75014 Paris PR:EMAIL clara.lambert@ibcp.fr PR:PHONE +33134652168 PR:PUBLICATIONS The double-edged role of FASII regulator FabT in Streptococcus pyogenes PR:PUBLICATIONS infection #STUDY ST:STUDY_TITLE The double-edged role of FASII regulator FabT in Streptococcus pyogenes ST:STUDY_TITLE infection - Lipidomics ST:STUDY_SUMMARY A FabT mutation impacts the membrane fatty acid (FA) composition. Lipids are ST:STUDY_SUMMARY composed of FA. The effects of the FabT mutation on membrane FA composition ST:STUDY_SUMMARY should also alter phospholipid metabolism. WT and mFabT strains were grown as ST:STUDY_SUMMARY 200 ml cultures in THY or THY-Tween until OD600 = 0.4 - 0.5. Lipid extractions ST:STUDY_SUMMARY and identifications were performed as described 1-4. Lipid separation was ST:STUDY_SUMMARY realized by normal phase HPLC (U3000 ThermoFisher Scientific) using a Inertsil ST:STUDY_SUMMARY Si 5μm column (150 x 2.1 mm I.D.) from GL Sciences Inc (Tokyo, Japan). Lipids ST:STUDY_SUMMARY were quantified using a Corona-CAD Ultra and identified by mass-spectrometry ST:STUDY_SUMMARY negative ionization and MS2/MS3 fragmentations (LTQ-Orbitrap Velos Pro). The ST:STUDY_SUMMARY adducts observed for molecular ions were: CH3COO- for MGDG, CH3COO- and H- for ST:STUDY_SUMMARY DGDG, H- for PG and CL. All raw data from MS/MS fragmentations can now be ST:STUDY_SUMMARY accessed in MZML open source format. This analysis was repeated on 3 independent ST:STUDY_SUMMARY experiments. 1-Kenanian, G. et al. Permissive Fatty Acid Incorporation Promotes ST:STUDY_SUMMARY Staphylococcal Adaptation to FASII Antibiotics in Host Environments. Cell Rep ST:STUDY_SUMMARY 29, 3974-3982 e3974, doi:10.1016/j.celrep.2019.11.071 (2019). 2-Abreu, S., ST:STUDY_SUMMARY Solgadi, A. & Chaminade, P. Optimization of normal phase chromatographic ST:STUDY_SUMMARY conditions for lipid analysis and comparison of associated detection techniques. ST:STUDY_SUMMARY J Chromatogr A 1514, 54-71, doi:10.1016/j.chroma.2017.07.063 (2017). 3-Bligh, E. ST:STUDY_SUMMARY G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can ST:STUDY_SUMMARY J Biochem Physiol 37, 911-917, doi:10.1139/o59-099 (1959). 4-Thedieck, K. et al. ST:STUDY_SUMMARY The MprF protein is required for lysinylation of phospholipids in listerial ST:STUDY_SUMMARY membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on ST:STUDY_SUMMARY Listeria monocytogenes. Mol Microbiol 62, 1325-1339, ST:STUDY_SUMMARY doi:10.1111/j.1365-2958.2006.05452.x (2006). ST:INSTITUTE INSERM ST:DEPARTMENT U1016 ST:LABORATORY Institut Cochin - Bacteria and perinatality team ST:LAST_NAME Lambert ST:FIRST_NAME Clara ST:ADDRESS 24 rue Méchain 75014 Paris ST:EMAIL clara.lambert@ibcp.fr ST:PHONE +33134652168 #SUBJECT SU:SUBJECT_TYPE Bacteria SU:SUBJECT_SPECIES Streptococcus pyogenes SU:GENOTYPE_STRAIN M28PF1 SU:GENDER Not applicable #FACTORS #SUBJECT_SAMPLE_FACTORS: SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data SUBJECT_SAMPLE_FACTORS Wild-type WT_THY_1 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=WT_THY_1 SUBJECT_SAMPLE_FACTORS Wild-type WT_THY_2 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=WT_THY_2 SUBJECT_SAMPLE_FACTORS Wild-type WT_THY_3 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=WT_THY_3 SUBJECT_SAMPLE_FACTORS Wild-type WT_THY_4 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=WT_THY_4 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY_1 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=mFabT_THY_1 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY_2 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=mFabT_THY_2 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY_3 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=mFabT_THY_3 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY_4 Sample source:Bacteria | Treatment:THY RAW_FILE_NAME(Raw file name)=mFabT_THY_4 SUBJECT_SAMPLE_FACTORS Wild-type WT_THY-Tween_1 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=WT_THY-Tween_1 SUBJECT_SAMPLE_FACTORS Wild-type WT_THY-Tween_2 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=WT_THY-Tween_2 SUBJECT_SAMPLE_FACTORS Wild-type WT_THY-Tween_3 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=WT_THY-Tween_3 SUBJECT_SAMPLE_FACTORS Wild-type WT_THY-Tween_4 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=WT_THY-Tween_4 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY-Tween_1 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=mFabT_THY-Tween_1 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY-Tween_2 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=mFabT_THY-Tween_2 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY-Tween_3 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=mFabT_THY-Tween_3 SUBJECT_SAMPLE_FACTORS FabT mutant strain mFabT_THY-Tween_4 Sample source:Bacteria | Treatment:THY-Tween RAW_FILE_NAME(Raw file name)=mFabT_THY-Tween_4 #COLLECTION CO:COLLECTION_SUMMARY Bacteria were grown as 200 ml cultures in THY or THY-Tween until OD600 = 0.4 - CO:COLLECTION_SUMMARY 0.5. Lipid extractions and identifications were performed as described 1-4. CO:COLLECTION_SUMMARY 1-Kenanian, G. et al. Permissive Fatty Acid Incorporation Promotes CO:COLLECTION_SUMMARY Staphylococcal Adaptation to FASII Antibiotics in Host Environments. Cell Rep CO:COLLECTION_SUMMARY 29, 3974-3982 e3974, doi:10.1016/j.celrep.2019.11.071 (2019). 2-Abreu, S., CO:COLLECTION_SUMMARY Solgadi, A. & Chaminade, P. Optimization of normal phase chromatographic CO:COLLECTION_SUMMARY conditions for lipid analysis and comparison of associated detection techniques. CO:COLLECTION_SUMMARY J Chromatogr A 1514, 54-71, doi:10.1016/j.chroma.2017.07.063 (2017). 3-Bligh, E. CO:COLLECTION_SUMMARY G. & Dyer, W. J. A rapid method of total lipid extraction and purification. Can CO:COLLECTION_SUMMARY J Biochem Physiol 37, 911-917, doi:10.1139/o59-099 (1959). 4-Thedieck, K. et al. CO:COLLECTION_SUMMARY The MprF protein is required for lysinylation of phospholipids in listerial CO:COLLECTION_SUMMARY membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on CO:COLLECTION_SUMMARY Listeria monocytogenes. Mol Microbiol 62, 1325-1339, CO:COLLECTION_SUMMARY doi:10.1111/j.1365-2958.2006.05452.x (2006). CO:SAMPLE_TYPE Bacterial cells #TREATMENT TR:TREATMENT_SUMMARY WT and mFabT strains were grown as 200 ml cultures in THY or THY-Tween until TR:TREATMENT_SUMMARY optical density at 600nm (D600) rich 0.4 - 0.5. #SAMPLEPREP SP:SAMPLEPREP_SUMMARY Lipid extractions and identifications were performed as described 1-4. Lipid SP:SAMPLEPREP_SUMMARY separation was realized by normal phase HPLC (U3000 ThermoFisher Scientific) SP:SAMPLEPREP_SUMMARY using a Inertsil Si 5μm column (150 x 2.1 mm I.D.) from GL Sciences Inc (Tokyo, SP:SAMPLEPREP_SUMMARY Japan). Lipids were quantified using a Corona-CAD Ultra and identified by SP:SAMPLEPREP_SUMMARY mass-spectrometry negative ionization and MS2/MS3 fragmentations (LTQ-Orbitrap SP:SAMPLEPREP_SUMMARY Velos Pro). The adducts observed for molecular ions were: CH3COO- for MGDG, SP:SAMPLEPREP_SUMMARY CH3COO- and H- for DGDG, H- for PG and CL. 1-Kenanian, G. et al. Permissive SP:SAMPLEPREP_SUMMARY Fatty Acid Incorporation Promotes Staphylococcal Adaptation to FASII Antibiotics SP:SAMPLEPREP_SUMMARY in Host Environments. Cell Rep 29, 3974-3982 e3974, SP:SAMPLEPREP_SUMMARY doi:10.1016/j.celrep.2019.11.071 (2019). 2-Abreu, S., Solgadi, A. & Chaminade, SP:SAMPLEPREP_SUMMARY P. Optimization of normal phase chromatographic conditions for lipid analysis SP:SAMPLEPREP_SUMMARY and comparison of associated detection techniques. J Chromatogr A 1514, 54-71, SP:SAMPLEPREP_SUMMARY doi:10.1016/j.chroma.2017.07.063 (2017). 3-Bligh, E. G. & Dyer, W. J. A rapid SP:SAMPLEPREP_SUMMARY method of total lipid extraction and purification. Can J Biochem Physiol 37, SP:SAMPLEPREP_SUMMARY 911-917, doi:10.1139/o59-099 (1959). 4-Thedieck, K. et al. The MprF protein is SP:SAMPLEPREP_SUMMARY required for lysinylation of phospholipids in listerial membranes and confers SP:SAMPLEPREP_SUMMARY resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. SP:SAMPLEPREP_SUMMARY Mol Microbiol 62, 1325-1339, doi:10.1111/j.1365-2958.2006.05452.x (2006). #CHROMATOGRAPHY CH:CHROMATOGRAPHY_TYPE Normal phase CH:INSTRUMENT_NAME ThermoFisher Ultimate 3000 RSLC CH:COLUMN_NAME Intersil si (150 x 2.1mm, 5um) CH:SOLVENT_A 100% heptane CH:SOLVENT_B 66.67% acetone/33.33% ethyl acetate; 0.15% acetic acid CH:SOLVENT_C 85% isopropanol/15% water; 0.043% acetic acid; 0.104 % triethylamine CH:FLOW_GRADIENT T(min) %A %B %C: 0 100 0 0; 1.5 100 0 0; 1.6 97 3 0; 9 94 6 0; 11 70 30 0; 14 45 CH:FLOW_GRADIENT 55 0; 15 45 55 0; 16 40 55 5; 20 35 55 10; 20.1 33 50 17; 25 38 45 17; 25.1 48 CH:FLOW_GRADIENT 35 17; 30 53 30 17; 40 40 0 60; 40.1 0 100 0; 42 0 100 0; 42.1 50 0 0; 45 50 0 CH:FLOW_GRADIENT 0; 47 100 0 0; 53 100 0 0 CH:FLOW_RATE 0.8mL/min CH:COLUMN_TEMPERATURE 40 #ANALYSIS AN:ANALYSIS_TYPE MS AN:LABORATORY_NAME UMS-IPSIT SAMM facility #MS MS:INSTRUMENT_NAME Thermo Velos LTQ Orbitrap MS:INSTRUMENT_TYPE LTQ-FT MS:MS_TYPE APCI MS:ION_MODE NEGATIVE MS:MS_COMMENTS Fulscan MS, data dependent analysis MS2 (top 2) and MS3 (top 1) Manual asignment MS:MS_COMMENTS compared to commercial standards (Abreu, S., Solgadi, A. & Chaminade, P. MS:MS_COMMENTS Optimization of normal phase chromatographic conditions for lipid analysis and MS:MS_COMMENTS comparison of associated detection techniques. J Chromatogr A 1514, 54-71, MS:MS_COMMENTS doi:10.1016/j.chroma.2017.07.063 (2017).) #MS_METABOLITE_DATA MS_METABOLITE_DATA:UNITS Relative abundance MS_METABOLITE_DATA_START Samples WT_THY_1 WT_THY_2 WT_THY_3 WT_THY_4 mFabT_THY_1 mFabT_THY_2 mFabT_THY_3 mFabT_THY_4 WT_THY-Tween_1 WT_THY-Tween_2 WT_THY-Tween_3 WT_THY-Tween_4 mFabT_THY-Tween_1 mFabT_THY-Tween_2 mFabT_THY-Tween_3 mFabT_THY-Tween_4 Factors Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY Sample source:Bacteria | Treatment:THY-Tween Sample source:Bacteria | Treatment:THY-Tween Sample source:Bacteria | Treatment:THY-Tween Sample source:Bacteria | Treatment:THY-Tween Sample source:Bacteria | Treatment:THY-Tween Sample source:Bacteria | Treatment:THY-Tween Sample source:Bacteria | Treatment:THY-Tween Sample source:Bacteria | Treatment:THY-Tween MGDG 32:2 7.30 9.79 13.48 7.41 0.67 0.58 0.86 0.55 4.67 3.42 4.39 2.13 0.29 0.24 0.44 0.30 MGDG 32:1 31.54 31.36 37.90 26.60 16.33 10.77 15.85 13.48 17.51 11.10 16.76 17.97 5.82 4.91 5.09 5.53 MGDG 34:3 3.72 5.32 6.94 4.46 0.25 0.31 0.49 0.24 0.80 0.56 0.62 0.24 0.12 0.16 0.29 0.12 MGDG 34:2 37.21 47.51 54.69 41.52 5.64 7.56 9.28 6.71 57.78 45.45 51.68 30.52 6.84 9.91 10.72 8.30 MGDG 34:1 100.00 100.00 100.00 100.00 100.00 92.61 98.84 90.60 97.91 64.18 86.55 100.00 100.00 100.00 100.00 100.00 MGDG 35:2 0.54 0.67 0.65 3.67 0.13 0.27 0.29 0.93 7.64 6.33 5.78 5.58 0.79 1.04 1.11 3.05 MGDG 35:1 0.73 0.73 0.76 3.20 1.38 1.55 1.62 7.49 5.50 4.32 3.68 2.19 5.14 4.98 5.46 9.76 MGDG 36:3 6.16 7.83 8.36 9.22 0.90 2.03 2.26 1.02 2.90 2.52 2.31 0.83 0.64 1.45 1.97 0.73 MGDG 36:2 36.55 42.20 41.87 51.25 12.16 27.41 26.62 18.23 100.00 100.00 100.00 64.52 30.83 48.94 55.91 44.15 MGDG 36:1 16.59 14.59 12.82 26.64 89.05 100.00 100.00 100.00 13.37 13.97 13.98 9.06 37.36 46.57 56.25 42.81 DGDG 32:2 14.7 15.81 13.62 4.13 1.83 2.17 2.22 0.65 4.11 5.33 3.8 0.94 0.58 0.82 0.89 0.28 DGDG 32:1 60.35 48.33 47.85 22.48 41.96 28.46 35.11 15.59 21.27 21.31 19.14 8.71 9.92 10.06 11.02 5.07 DGDG 34:2 37.53 43.56 39.69 23.84 6.87 9.77 9.59 3.57 31.29 39.58 31.94 11.08 8.02 10.49 10.92 4.25 DGDG 34:1 100 100 100 68.45 100 100 100 59.49 100 100 100 61.56 100 100 100 67.72 DGDG 36:2 26.75 33.04 27.83 23.91 7.89 17.86 15.67 7.18 49.14 70.57 61.21 27.93 26.36 34.06 36.77 19.32 DGDG 36:1 18.16 18.08 13.82 14.17 65.77 75.77 74.91 45.75 8.1 12.88 10.63 3.66 26.54 35.89 35.58 19.08 PG 28:0 16.2 4.42 2.17 8.54 3.15 0.32 1.58 2.87 1.74 0.22 0.71 3.03 0.75 0.03 0.19 0.75 PG 30:2 9.65 5.43 3.15 7.72 0.82 0.26 0.85 1.44 1.25 0.25 0.52 1.15 0.11 0.02 0.1 0.15 PG 30:1 35.21 24.97 21.62 23.96 8.47 3.76 8.15 8.13 32.15 14.67 22.19 25.64 2.8 0.7 1.76 2.62 PG 30:0 28.63 21.07 24.86 15 8.53 2.83 4.45 3.76 18.57 9.3 14.64 25.99 4.88 2.23 3.52 3.43 PG 32:2 32.69 33.61 36.42 25.73 4.2 3.25 5.53 4.59 18.86 14.28 16.87 11.95 1.53 1.08 1.93 1.52 PG 32:1 70.81 67.93 79.53 56.95 40.4 27.03 38.94 35.64 100 80.77 100 100 14.1 12.17 13.56 13.84 PG 32:0 12.99 7.66 12.64 4.51 5.18 0.13 3.17 2.63 0.01 0 0.01 0.01 7.77 4.57 5.82 4.65 PG 33:1 0.75 0.9 1.17 2.11 0.42 0.44 0.48 1.46 17.47 19.13 19.12 14.15 2.7 2.06 1.89 3.33 PG 34:3 9.55 10.99 11.59 8.88 0.5 0.91 1.63 0.05 0.68 0.74 0.6 0.35 0.2 0.33 0.64 0.21 PG 34:2 59.81 70.35 78.48 57.38 11.94 17.76 20.3 15.52 69.47 76.87 71.64 40.04 13.26 16.71 19.27 15.13 PG 34:1 100 100 100 100 100 100 100 100 65.81 70.11 79.87 78.46 100 100 100 100 PG 36:3 7.55 8.34 7.67 8.43 0.74 3.25 3.98 1.61 2.5 2.79 2.2 0.91 0.69 1.63 2.9 0.72 PG 36:2 40.75 33.73 26.84 46.64 14.51 39.96 35.23 23.45 83.54 100 89.7 63.6 28.77 42.68 47.61 35.82 PG 36:1 18.36 8.88 5.43 25.34 83.51 88.99 88.84 88.56 9.99 11.39 10.36 7.36 23.36 36.82 40.77 27.67 CL 62:2 60.67 51.75 49.88 32.83 2.69 2.52 2.47 2.73 29.63 30.46 28.86 24.66 0.33 0.44 0.44 0.41 CL 62:1 44.95 29.46 32.2 16.95 4.21 2.41 3.34 2.77 20.72 14.61 20.08 30.14 0.95 0.71 1.17 0.98 CL 64:4 18.97 24.76 24.52 15.9 0.60 0.76 0.69 0.65 3.17 3.90 2.65 13.16 0.07 0.13 0.11 0.01 CL 64:3 60.71 69.42 71.2 48.69 3.06 2.76 3.29 3.5 30.93 44.09 32.64 16.08 0.65 0.78 1.13 0.73 CL 64:2 95.02 91.5 93.35 67.55 21.09 11.81 14.72 14.08 88.21 88.57 87.53 83.8 5.19 4.83 5.75 4.17 CL 64:1 39.27 31.01 28.79 17.17 9.56 5.40 6.48 4.01 24.67 20.79 30.79 36.48 5.32 4.54 6.37 3.98 CL 65:2 1.78 1.87 2.16 3.43 0.68 0.61 0.70 1.16 17.51 20.04 17.21 13.77 1.09 1.34 1.03 1.23 CL 66:4 32.46 43.71 47.62 2.19 2.22 2.48 2.52 2.17 10.13 16.58 9.60 4.62 0.56 0.78 0.98 0.61 CL 66:3 89.77 100 100 88.55 14.15 13.92 14.35 12.75 79.21 100 78.85 44.94 5.13 7.33 7.17 4.92 CL 66:2 100 91.27 76.98 94.59 71.96 48.92 51.84 49.09 100 83.44 100 100 26.77 27.17 26.19 21.07 CL 68:4 35.26 42.91 39.86 43.55 4.48 8.81 6.73 4.7 23.73 33.86 24.5 8.7 2.07 4.18 4.00 4.63 CL 68:3 70.78 73.73 53.09 100 29.99 44.41 38.02 32.48 79.94 83.89 94.09 57.62 27.48 36.43 34.24 27.8 CL 68:2 48.82 39.39 18.19 76.05 100 100 96.17 100 32.45 0.20 51.44 40.74 100 100 100 100 CL 70:4 14.42 15.84 11.8 27.92 4.72 14.78 10.62 7.28 17.3 22.55 28.47 9.3 5.14 10.54 10.69 6.55 CL 70:3 15.06 14.06 7.84 38.31 21.2 52.11 46.33 39.06 12.78 5.35 32.50 19.11 40.08 49.69 62.37 45.54 CL 70:2 4.15 4.48 2.19 11.15 43.46 56.2 71.28 75.55 4.83 2.25 9.48 6.15 36.33 28.26 54.78 30.51 DeoxCL 64:4 38.52 45.11 51.18 28.23 2.37 1.31 2.89 1.94 21.62 35.07 24.31 11.19 0.45 0.41 0.11 1.1 DeoxCL 64:3 56.9 57.66 70.19 37.75 15.19 8.03 12.82 7.85 63.7 72.44 60.04 64.71 3.53 3.27 0.94 5.83 DeoxCL 64:2 17.68 17.13 20.7 9.13 6.01 3.44 5.21 1.91 15.66 16.61 15.17 28.9 3.46 3.07 1.5 5.41 DeoxCL 66:5 21.6 32.95 41.07 20.45 1.42 1.23 2.14 1.22 8.29 14.04 6.09 3.42 0.38 0.56 0.69 0.29 DeoxCL 66:4 60.82 76.44 86.06 61.3 11.29 9.36 13.33 7.49 63.26 94.51 47.4 44.82 4.38 5.25 4.80 2.58 DeoxCL 66:3 63.36 67.46 62.59 57.69 51.63 34.2 46.92 29.52 79.2 74.64 54.79 99.61 22.05 20.48 16.62 11.1 DeoxCL 68:5 25.94 37.73 39.32 31.22 3.7 6.52 7.03 3.44 21.22 33.01 14.34 8.31 1.93 3.65 2.79 1.6 DeoxCL 68:4 52.26 66.63 52.7 71.08 24.83 34.29 39.89 22.98 70.16 80.58 62.87 63.17 23.97 31.8 23.08 16.54 DeoxCL 68:3 32.7 32.41 18.59 48.49 82.24 75.82 100 69.41 26.21 3.35 1.75 44.9 90.45 85.35 66.97 60.31 DeoxCL 70:5 12.03 16.43 10.44 21.04 4.55 13.06 12.70 5.86 15.84 13.82 22.87 10.53 4.67 9.47 6.96 4.61 DeoxCL 70:4 11.62 13.54 6.69 28.4 18.66 50.76 53.87 0.15 12.31 5.73 26.37 22.15 38.74 47.34 43.25 30.54 DeoxCL 70:3 0.01 3.88 2.84 7.6 41.92 49.54 84.74 56.93 4.66 4.35 7.45 7.07 34.65 26.07 39.82 17.27 MS_METABOLITE_DATA_END #METABOLITES METABOLITES_START metabolite_name m/z values MGDG 32:2 785.54 MGDG 32:1 787.56 MGDG 34:3 811.56 MGDG 34:2 813.57 MGDG 34:1 815.59 MGDG 35:2 827.59 MGDG 35:1 829.6 MGDG 36:3 839.59 MGDG 36:2 841.6 MGDG 36:1 843.62 DGDG 32:2 947.59 DGDG 32:1 949.61 DGDG 34:2 975.62 DGDG 34:1 977.64 DGDG 36:2 1003.65 DGDG 36:1 1005.67 PG 28:0 665.44 PG 30:2 689.44 PG 30:1 691.45 PG 30:0 693.47 PG 32:2 717.47 PG 32:1 719.48 PG 32:0 721.5 PG 33:1 733.5 PG 34:3 743.48 PG 34:2 745.5 PG 34:1 747.51 PG 36:3 771.51 PG 36:2 773.53 PG 36:1 775.55 CL 62:2 1319.9 CL 62:1 1321.91 CL 64:4 1343.9 CL 64:3 1345.91 CL 64:2 1347.93 CL 64:1 1349.95 CL 65:2 1361.95 CL 66:4 1371.93 CL 66:3 1373.94 CL 66:2 1375.96 CL 68:4 1399.96 CL 68:3 1401.98 CL 68:2 1403.99 CL 70:4 1427.99 CL 70:3 1430.01 CL 70:2 1432.02 DeoxCL 64:4 1327.9 DeoxCL 64:3 1329.92 DeoxCL 64:2 1331.93 DeoxCL 66:5 1353.92 DeoxCL 66:4 1355.93 DeoxCL 66:3 1357.95 DeoxCL 68:5 1381.95 DeoxCL 68:4 1383.97 DeoxCL 68:3 1385.98 DeoxCL 70:5 1409.98 DeoxCL 70:4 1412 DeoxCL 70:3 1414.01 METABOLITES_END #END